Exploratory study of the effect of lifestyle counselling on bone mineral density and body composition in users of the contraceptive depot- medroxyprogesterone acetate

European Journal of Contraception and Reproductive Health Care

Volumn 19, Issue 4, 2014, Pages 244-249

  Modesto, Waleska ^a   Bahamondes, M Valeria ^a   Silva Dos Santos, Priscila ^a   Fernandes, Arlete ^a   Dal'ava, Natalia ^a   Bahamondes, Luis ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Body composition; Bone mineral density; Depot medroxyprogesterone acetate

Indexed keywords

COPPER INTRAUTERINE DEVICE; MEDROXYPROGESTERONE ACETATE; VITAMIN D; CALCIUM INTAKE; CONTRACEPTIVE AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY COMPOSITION; BODY MASS; BONE DENSITY; CALCIUM INTAKE; CONTRACEPTION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HORMONAL CONTRACEPTION; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SIDE EFFECT; SUN EXPOSURE; WALKING; ADMINISTRATION AND DOSAGE; ADOLESCENT; CHEMICALLY INDUCED; CLINICAL TRIAL; COUNSELING; DRUG EFFECTS; LIFESTYLE; MOTOR ACTIVITY; OSTEOPOROSIS; SUNLIGHT; WEIGHT GAIN; YOUNG ADULT;

ADOLESCENT; ADULT; BODY COMPOSITION; BONE DENSITY; CALCIUM, DIETARY; CONTRACEPTIVE AGENTS, FEMALE; COUNSELING; FEMALE; HUMANS; LIFE STYLE; MEDROXYPROGESTERONE ACETATE; MOTOR ACTIVITY; OSTEOPOROSIS; SUNLIGHT; WEIGHT GAIN; YOUNG ADULT;

EID: 84904666161     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.3109/13625187.2014.924098     Document Type: Article

References (23)

1. Scholes D, La Croix AZ, Ichikawa L E, et al. Injectable hormone contraception and bone density: Results from a prospective study. Epidemiology 2002; 13: 581-7.
2. Berenson A B, Breitkopf CR, Grady JJ, et al. Effects of hormonal contraception on bone mineral density after 24 months of use. Obstet Gynecol 2004; 103: 899-906.
3. Cundy T, Cornish J, Roberts H, et al. Spinal bone density in women using depot medroxyprogesterone contraception. Obstet Gynecol 1998; 92: 569-73.
4. Scholes D, La Croix A Z, Ott S M, et al. Bone mineral density in women using depot medroxyprogesterone acetate for contraception. Obstet Gynecol 1999; 93: 233-8.
5. Berenson A B, Radecki C M, Grady J J, et al. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol 2001; 98: 576-82.
6. Wetmore C M, Ichikawa L, LaCroix A Z, et al. Association between caffeine intake and bone mass among young women: Potential effect modification by depot medroxyprogesterone acetate use. Osteoporos Int 2008; 19: 519-27.
7. B erenson A B, Rahman M, Breitkopf C R, et al. Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density. Obstet Gynecol 2008; 112: 788-99.
8. Clark MK, S owers MR, N ichols S, et al. B one mineral density changes over two years in first-Time users of depot medroxyprogesterone acetate. Fertil Steril 2004; 82: 1580-6.
9. Clark MK, Sowers M, Levy B, et al. Bone mineral density loss and recovery during 48 months in first-Time users of depot medroxyprogesterone acetate. Fertil Steril 2006; 86: 1466-74.
10. Wanichsetakul P. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depo-medroxyprogesterone acetate for contraception. Contraception 2002; 65: 407-10.
11. Kaunitz AM, Miller PD, Rice VM, et al. Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: Recovery following discontinuation. Contraception 2006; 74: 90-9.
12. Albertazzi P, Bottazzi M, Steel SA. Bone mineral density and depot medroxyprogesterone acetate. Contraception 2006; 73: 577-83.
13. Consensus Development Conference. Prophylaxis and treatment of osteoporosis. Osteoporos Int 1991; 1: 114-7.
14. WarensjoE, Byberg L, Melhus H, et al. Dietary calcium intake and risk of fracture and osteoporosis: Prospective longitudinal cohort study. BMJ 2011; 24: D1473.
15. Michaëlsson K, Melhus H, Bellocco R, et al. Dietary calcium and vitamin D intake in relation to osteoporotic fracture risk. Bone 2003; 32: 694-703.
16. Feskanich D, Willett WC, Colditz GA. Calcium, vitamin D, milk consumption, and hip fractures: A prospective study among postmenopausal women. Am J Clin Nutr 2003; 77: 504-11.
17. Pludowski P, Holick M F, Pilz S, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-A review of recent evidence. Autoimmun Rev 2013; 12: 976-89.
18. Murad HM, Elamin KB, Abu Elnour NO, et al. The effect of vitamin D on falls: A systematic review and metaanalysis. J Clin Endocrinol Metab 2011; 96: 2997-3006.
19. Ahola R, Korpelainen R, Vainionpaa A, et al. Daily impact score in long-Term acceleration measurements of exercise. J Biomech 2010; 43: 1960-4.
20. Berenson AB, Rahman M. Changes in weight, total fat, percent body fat, and central-To-peripheral fat ratio associated with injectable and oral contraceptive use. Am J Obstet Gynecol 2009; 200:329, e1-8.
21. Clark M K, Dillon J S, Sowers M, et al. Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception. Int J Obes 2005; 29: 1252-8.
22. Frost HM, Schonau E. The muscle-bone unit in children and adolescents. J Pediatr Endocrinol Metab 2000; 13: 571-90.
23. Babatunde O O, Forsyth J J. Association between depot medroxyprogesterone acetate (DMPA), physical activity and bone health. J Bone Miner Metab 2013; 32: 305-11.